About Illumina, Inc.
Illumina, Inc. (ILMN) has been publicly traded since 2000, making it a 26-year-old public company. It operates in the Diagnostics & Research industry within the Healthcare sector. The company is headquartered in San Diego, United States and employs approximately 8,600 people. With a market capitalization of $18 billion, ILMN is a large established company.
Key Statistics
- Current Price
- $118.94
- Market Cap
- $18.19B
- 52-Week High
- $155.53
- 52-Week Low
- $68.70
- Sector
- Healthcare
- Industry
- Diagnostics & Research
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -9.32% | $131.16 | $118.94 |
| 2025 | -1.85% | $133.63 | $131.16 |
| 2024 | -1.34% | $135.45 | $133.63 |
| 2023 | -31.14% | $196.69 | $135.45 |
| 2022 | -46.85% | $370.08 | $196.69 |
| 2021 | +2.82% | $359.92 | $370.08 |
| 2020 | +11.53% | $322.70 | $359.92 |
| 2019 | +10.61% | $291.76 | $322.70 |
| 2018 | +37.27% | $212.54 | $291.76 |
| 2017 | +70.64% | $124.55 | $212.54 |
| 2016 | -33.30% | $186.72 | $124.55 |
| 2015 | +3.99% | $179.55 | $186.72 |
| 2014 | +66.90% | $107.58 | $179.55 |
| 2013 | +98.94% | $54.08 | $107.58 |
| 2012 | +82.38% | $29.65 | $54.08 |
| 2011 | -51.88% | $61.61 | $29.65 |
| 2010 | +106.45% | $29.84 | $61.61 |
| 2009 | +17.77% | $25.34 | $29.84 |
| 2008 | -12.08% | $28.82 | $25.34 |
| 2007 | +50.75% | $19.12 | $28.82 |
| 2006 | +178.79% | $6.86 | $19.12 |
| 2005 | +48.73% | $4.61 | $6.86 |
| 2004 | +34.47% | $3.43 | $4.61 |
| 2003 | +109.20% | $1.64 | $3.43 |
| 2002 | -71.34% | $5.72 | $1.64 |
| 2001 | -26.79% | $7.81 | $5.72 |
Valuation
ILMN currently trades at a trailing P/E ratio of 21.8, which is considered moderate relative to the broader market. The forward P/E of 20.4 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 6.7. The price-to-sales ratio is 4.2.
Dividends
Illumina, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
ILMN has a beta of 1.50, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $68.70 to $155.53, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 19 analyst opinions, ILMN has a consensus "buy" rating. The average price target of $136.05 suggests 14.4% upside from current levels.
Frequently Asked Questions
What does Illumina, Inc. do? ▼
Illumina, Inc. is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in San Diego, United States.
What sector is ILMN in? ▼
ILMN operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
When did ILMN go public? ▼
Illumina, Inc. went public in 2000, making it a 26-year-old public company as of 2026.
How much would $1,000 invested in ILMN 5 years ago be worth today? ▼
A $1,000 investment in ILMN five years ago would be worth approximately $305 today, representing a -69.5% return.
Does ILMN pay dividends? ▼
No, Illumina, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is ILMN's market cap? ▼
Illumina, Inc. has a market capitalization of $18 billion, classifying it as a large-cap company.
What is ILMN's P/E ratio? ▼
ILMN has a trailing P/E ratio of 21.8 and a forward P/E of 20.4, which measures how much investors are paying per dollar of earnings.
Is ILMN a buy, hold, or sell? ▼
Based on 19 opinions, ILMN has a consensus "buy" rating. The average price target is $136.05.
Last updated: 3/14/2026